We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

156 hedge funds and large institutions have $703M invested in Aerie Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more capital invested

Capital invested by funds: $354M → $703M (+$350M)

58% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 33

34% more call options, than puts

Call options by funds: $610K | Put options by funds: $454K

14% more funds holding

Funds holding: 137 → 156 (+19)

4% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 45

Holders
156
Holders Change
+19
Holders Change %
+13.87%
% of All Funds
2.69%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
52
Increased
47
Reduced
45
Closed
33
Calls
$610K
Puts
$454K
Net Calls
+$156K
Net Calls Change
+$65K

Top Buyers

Rank Fund Capital Flow
1
WIC
Water Island Capital
New York
+$24.2M
2
NAM
Nexpoint Asset Management
Texas
+$18.4M
3
AA
AQR Arbitrage
Connecticut
+$12.5M
4
AAM
Alpine Associates Management
Florida
+$12M
5
Goldman Sachs
Goldman Sachs
New York
+$9.16M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$17.7M
2
Ameriprise
Ameriprise
Minnesota
-$15.1M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$11.4M
4
RCMNY
Rubric Capital Management (New York)
New York
-$9.24M
5
CWG
C WorldWide Group
Denmark
-$8.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
Los Angeles Capital Management
51
Los Angeles Capital Management
California
$1.76M +$836K +71,907 +161%
Ameriprise
52
Ameriprise
Minnesota
$1.76M -$15.1M -1,302,754 -92%
Swiss National Bank
53
Swiss National Bank
Switzerland
$1.57M +$13.9K +1,200 +1%
DAM
54
DLD Asset Management
New York
$1.51M +$1.16M +100,000 New
Two Sigma Advisers
55
Two Sigma Advisers
New York
$1.48M +$925K +79,600 +435%
Nordea Investment Management
56
Nordea Investment Management
Sweden
$1.34M -$7.13K -613 -0.7%
PCM
57
Prelude Capital Management
New York
$1.26M +$965K +83,004 New
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
$1.2M +$141K +12,099 +18%
TIM
59
Thompson Investment Management
Wisconsin
$1.13M – – –
AGM
60
Alpine Global Management
New York
$1.09M +$835K +71,825 New
SG Americas Securities
61
SG Americas Securities
New York
$1.05M +$612K +52,635 +314%
AllianceBernstein
62
AllianceBernstein
Tennessee
$1.05M +$53.5K +4,600 +7%
Walleye Capital
63
Walleye Capital
New York
$1.02M -$6.56M -564,180 -89%
BCM
64
BCK Capital Management
Connecticut
$968K +$744K +64,000 New
New York State Common Retirement Fund
65
New York State Common Retirement Fund
New York
$924K -$579K -49,818 -45%
CANY
66
Caxton Associates (New York)
New York
$923K +$342K +29,458 +93%
PP
67
PDT Partners
New York
$910K -$1.13M -96,873 -62%
Prudential Financial
68
Prudential Financial
New Jersey
$894K +$686K +59,040 New
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$854K -$13.7K -1,179 -2%
UBS AM
70
UBS AM
Illinois
$810K +$26.9K +2,310 +5%
CC
71
Centiva Capital
New York
$757K +$581K +50,000 New
HM
72
Harvest Management
New York
$757K +$581K +50,000 New
SEI Investments
73
SEI Investments
Pennsylvania
$743K +$13.4K +1,149 +2%
Tudor Investment Corp
74
Tudor Investment Corp
Connecticut
$739K +$568K +48,874 New
Squarepoint
75
Squarepoint
New York
$724K -$186K -16,035 -25%
1 2
3
4 5

AERI Hedge Fund Activity: Q3 2022 in Review

156 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q3 2022, worth a combined $703M — up 99% from $354M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new AERI positions and 33 closed out — a net gain of 19 holders — while 47 added to existing stakes and 45 trimmed.

The largest buyer was Water Island Capital, opening a new position worth an estimated $24.2M. The largest seller was Bank of America, cutting an estimated $17.7M.

  • 156 institutional investors held Aerie Pharmaceuticals (AERI) as of Q3 2022, up from 137 in Q2 2022.
  • Funds reported $703M of Aerie Pharmaceuticals stock for Q3 2022, up 99% quarter-over-quarter.
  • 52 funds opened new Aerie Pharmaceuticals positions in Q3 2022 and 33 closed out, a net change of +19 holders.
  • The largest Aerie Pharmaceuticals buyer in Q3 2022 was Water Island Capital, an estimated $24.2M added.
  • The largest Aerie Pharmaceuticals seller in Q3 2022 was Bank of America, an estimated $17.7M sold.

Based on aggregated 13F filings for Q3 2022.